The binding of the receptor binding domain (RBD) of the SARS-CoV-2 spike protein to the host cell receptor angiotensin-converting enzyme 2 (ACE2) is the first step in human viral infection. Therefore, understanding the mechanism of interaction between RBD and ACE2 at the molecular level is critical for the prevention of COVID-19, as more variants of concern, such as Omicron, appear. Recently, atomic force microscopy has been applied to characterize the free energy landscape of the RBD–ACE2 complex, including estimation of the distance between the transition state and the bound state, xu. Here, using a coarse-grained model and replica-exchange umbrella sampling, we studied the free energy landscape of both the wild type and Omicron subvariants BA.1 and XBB.1.5 interacting with ACE2. In agreement with experiment, we find that the wild type and Omicron subvariants have similar xu values, but Omicron binds ACE2 more strongly than the wild type, having a lower dissociation constant KD.
REFERENCES
1.
D.
Wrapp
, N.
Wang
, K. S.
Corbett
, J. A.
Goldsmith
, C.-L.
Hsieh
, O.
Abiona
, B. S.
Graham
, and J. S.
McLellan
, “Cryo-EM structure of the 2019-nCoV spike in the prefusion
conformation
,” Science
367
, 1260
–1263
(2020
).2.
Q.
Wang
, Y.
Zhang
, L.
Wu
, S.
Niu
, C.
Song
, Z.
Zhang
, G.
Lu
, C.
Qiao
, Y.
Hu
, K. Y.
Yuen
, Q.
Wang
, H.
Zhou
, J.
Yan
, and J.
Qi
, “Structural and functional basis of SARS-CoV-2 entry by using human ACE2
,” Cell
181
, 894
–904e9
(2020
).3.
J.
Shang
, G.
Ye
, K.
Shi
, Y.
Wan
, C.
Luo
, H.
Aihara
, Q.
Geng
, A.
Auerbach
, and F.
Li
,
“Structural basis of receptor recognition by SARS-CoV-2
,” Nature
581
, 221
–224
(2020
).4.
K. K.
Chan
, D.
Dorosky
, P.
Sharma
, S. A.
Abbasi
, J. M.
Dye
, D. M.
Kranz
, A. S.
Herbert
, and E.
Procko
, “Engineering human ACE2 to optimize binding to the spike protein of SARS
coronavirus 2
,” Science
369
, 1261
–1265
(2020
).5.
H. L.
Nguyen
, P. D.
Lan
, N. Q.
Thai
, D. A.
Nissley
, E. P.
O’Brien
, and M. S.
Li
, “Does SARS-CoV-2 bind to human ACE2 more strongly than does SARS-CoV?
,” J. Phys. Chem. B
124
, 7336
–7347
(2020
).6.
H.-m.
Ding
, Y.-w.
Yin
, S. d.
Ni
, Y. j.
Sheng
, and Y. q.
Ma
, “Accurate evaluation on the interactions of SARS-CoV-2 with its receptor ACE2 and antibodies CR3022/CB6
,” Chin. Phys Lett
38
, 018701
(2021
).7.
E. G.
Coderc de Lacam
, M.
Blazhynska
, H.
Chen
, J. C.
Gumbart
, and C.
Chipot
, “When the dust has settled: Calculation of binding affinities from first principles for SARS-CoV-2 variants with quantitative accuracy
,” J. Chem. Theory Comput.
18
, 5890
–5900
(2022
).8.
B.
Jawad
, P.
Adhikari
, R.
Podgornik
, and W.-Y.
Ching
, “Key interacting residues between RBD of SARS-CoV-2 and ACE2 receptor: Combination of molecular dynamics simulation and density functional calculation
,” J. Chem. Inf. Model.
61
, 4425
–4441
(2021
).9.
G. K.
Naresh
and L.
Guruprasad
, “Mutations in the receptor-binding domain of human SARS CoV-2 spike protein increases its affinity to bind human ACE-2 receptor
,” J. Biomol. Struct. Dyn.
41
, 2368
–2381
(2023
).10.
N.
Forouzesh
and N.
Mishra
, “An effective MM/GBSA protocol for absolute binding free energy calculations: A case study on SARS-CoV-2 spike protein and the human ACE2 receptor
,” Molecules
26
, 2383
(2021
).11.
Y.
Zhang
, X.
He
, J.
Zhai
, B.
Ji
, V. H.
Man
, and J.
Wang
, “In silico binding profile characterization of SARS-CoV-2 spike protein and its mutants bound to human ACE2 receptor
,” Briefings Bioinf.
22
, bbab188
(2021
).12.
H. L.
Nguyen
, N. Q.
Thai
, P. H.
Nguyen
, and M. S.
Li
, “SARS-CoV-2 omicron variant binds to human cells more strongly than the wild type: Evidence from molecular dynamics simulation
,” J. Phys. Chem. B
126
, 4669
–4678
(2022
).13.
J.
de Andrade
, P. F. B.
Gonçalves
, and P. A.
Netz
, “Why does the novel coronavirus spike protein interact so strongly with the human ACE2? A thermodynamic answer
,” ChemBioChem
22
, 865
–875
(2021
).14.
K.
Nguyen
, S.
Chakraborty
, R. A.
Mansbach
, P. D.
Manrique
, B.
Korber
, and S.
Gnanakaran
, “Exploring the role of glycans in the interaction of SARS-CoV-2 RBD and human receptor ACE2
,” Biophys. J.
120
, 15a
(2021
).15.
F.
Tian
, B.
Tong
, L.
Sun
, S.
Shi
, B.
Zheng
, Z.
Wang
, X.
Dong
, and P.
Zheng
, “N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2
,”
Elife
10
, e69091
(2021
).16.
C.
Motozono
, M.
Toyoda
, J.
Zahradnik
, A.
Saito
, H.
Nasser
, T. S.
Tan
, I.
Ngare
, I.
Kimura
, K.
Uriu
,
Y.
Kosugi
et al, “SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
,” Cell Host Microbe
29
, 1124
–1136e11
(2021
).17.
Y.
Wang
, C.
Liu
, C.
Zhang
, Y.
Wang
, Q.
Hong
, S.
Xu
, Z.
Li
, Y.
Yang
, Z.
Huang
, and Y.
Cong
, “Structural basis for SARS-CoV-2 Delta variant recognition of ACE2 receptor and broadly neutralizing antibodies
,” Nat. Commun.
13
, 871
(2022
).18.
R.
Viana
, S.
Moyo
, D. G.
Amoako
, H.
Tegally
, C.
Scheepers
, C. L.
Althaus
, U. J.
Anyaneji
, P. A.
Bester
, M. F.
Boni
, M.
Chand
et al, “Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
,” Nature
603
, 679
–686
(2022
).19.
E.
Socher
, L.
Heger
, F.
Paulsen
, F.
Zunke
, and P.
Arnold
, “Molecular dynamics simulations of the delta and omicron SARS-CoV-2 spike—ACE2 complexes reveal distinct changes between both variants
,” Comput. Struct. Biotechnol. J.
20
, 1168
–1176
(2022
).20.
T. N.
Starr
, A. J.
Greaney
, W. W.
Hannon
, A. N.
Loes
, K.
Hauser
, J. R.
Dillen
, E.
Ferri
, A. G.
Farrell
, B.
Dadonaite
, M.
McCallum
et al, “Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution
,” Science
377
, 420
–424
(2022
).21.
A.
Moulana
, T.
Dupic
, A. M.
Phillips
, J.
Chang
, S.
Nieves
, A. A.
Roffler
, A. J.
Greaney
, T. N.
Starr
, J. D.
Bloom
, and M. M.
Desai
, “Compensatory epistasis maintains ACE2 affinity in SARS-CoV-2 Omicron BA.1
,” Nat. Commun.
13
, 7011
(2022
).22.
T.
Tada
, H.
Zhou
, B. M.
Dcosta
, M. I.
Samanovic
, V.
Chivukula
, R. S.
Herati
, S. R.
Hubbard
, M. J.
Mulligan
, and N. R.
Landau
, “Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies
,” EBioMedicine
78
, 103944
(2022
).23.
C.
Yue
, W.
Song
, L.
Wang
, F.
Jian
, X.
Chen
, F.
Gao
, Z.
Shen
, Y.
Wang
, X.
Wang
, and Y.
Cao
, “ACE2 binding and antibody evasion in enhanced transmissibility of XBB.1.5
,” Lancet Infect. Dis.
23
, 278
(2023
).24.
K.
Uriu
, J.
Ito
, J.
Zahradnik
, S.
Fujita
, Y.
Kosugi
, G.
Schreiber
, and K.
Sato
, “Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant
,” Lancet Infect. Dis.
23
,
280
–281
(2023
).25.
D.
Mannar
, J. W.
Saville
, X.
Zhu
, S. S.
Srivastava
, A. M.
Berezuk
, K. S.
Tuttle
, A. C.
Marquez
, I.
Sekirov
, and S.
Subramaniam
, “SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex
,” Science
375
, 760
–764
(2022
).26.
J. W.
Saville
, D.
Mannar
, X.
Zhu
, A. M.
Berezuk
, S.
Cholak
, K. S.
Tuttle
, F.
Vahdatihassani
, and S.
Subramaniam
, “Structural analysis of receptor engagement and antigenic drift
within the BA.2 spike protein
,” Cell Rep.
42
, 111964
(2023
).27.
Z.
Cui
, P.
Liu
, N.
Wang
, L.
Wang
, K.
Fan
, Q.
Zhu
, K.
Wang
, R.
Chen
, R.
Feng
, Z.
Jia
, M.
Yang
, G.
Xu
, B.
Zhu
, W.
Fu
, T.
Chu
, L.
Feng
, Y.
Wang
, X.
Pei
, P.
Yang
, X. S.
Xie
, L.
Cao
, Y.
Cao
, and X.
Wang
, “Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron
,” Cell
185
, 860
–871.e13
(2022
).28.
Q.
Geng
, K.
Shi
, G.
Ye
, W.
Zhang
, H.
Aihara
, and F.
Li
, “Structural basis for human receptor recognition by SARS-CoV-2 omicron variant BA.1
,” J. Virol.
96
, e00249
–e00222
(2022
).29.
S.
Kumar
, T. S.
Thambiraja
, K.
Karuppanan
, and G.
Subramaniam
, “Omicron and delta variant of SARS-CoV-2: A comparative computational study of spike protein
,” J. Med. Virol.
94
, 1641
–1649
(2022
).30.
M.
Shah
and H. G.
Woo
, “Omicron: A heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escapes approved COVID-19 therapeutic antibodies
,” Front. Immunol.
12
, 830527
(2022
).31.
B.
Jawad
, P.
Adhikari
, R.
Podgornik
, and W. Y.
Ching
, “Binding interactions between receptor-binding domain of spike protein and human angiotensin converting enzyme-2 in omicron variant
,” J. Phys. Chem. Lett.
13
, 3915
–3921
(2022
).32.
S.
Kim
, Y.
Liu
, M.
Ziarnik
, S.
Seo
, Y.
Cao
, X. F.
Zhang
, and W.
Im
, “Binding of human ACE2 and RBD of omicron enhanced by unique interaction patterns among SARS-CoV-2 variants of concern
,” J. Comput. Chem.
44
,
594
–601
(2023
).33.
L.
Wu
, L.
Zhou
, M.
Mo
, T.
Liu
, C.
Wu
, C.
Gong
, K.
Lu
, L.
Gong
, W.
Zhu
, and Z.
Xu
, “SARS-CoV-2 Omicron RBD shows weaker binding affinity than the currently dominant Delta variant to human ACE2
,” Signal Transduction Targeted Ther.
7
, 8
(2022
).34.
J. K.
Singh
, J.
Singh
, and S. K.
Srivastava
, “Investigating the role of glycans in Omicron sub-lineages XBB. 1.5 and XBB. 1.16 binding to host receptor using molecular dynamics and binding free energy calculations
,” J. Comput. Aided Mol. Des.
37
, 551
(2023
).35.
A.
Sugano
, H.
Kataguchi
, M.
Ohta
, Y.
Someya
, S.
Kimura
, Y.
Maniwa
, T.
Tabata
, and Y.
Takaoka
, “SARS-CoV-2 omicron XBB. 1.5 may Be a variant that spreads more widely and faster than
other variants
,” bioRxiv: (2023
). 36.
H.
Nguyen
, H. L.
Nguyen
, P. D.
Lan
, N. Q.
Thai
, M.
Sikora
, and M. S.
Li
, “Interaction of SARS-CoV-2 with host cells and antibodies: Experiment and simulation
,” Chem. Soc. Rev.
52
, 6497
–6553
(2023
).37.
H.
Nguyen
, P. D.
Lan
, D. A.
Nissley
, E. P.
O’Brien
, and M. S.
Li
, “Electrostatic interactions explain the higher binding affinity of the CR3022 antibody for SARS-CoV-2 than the 4A8 antibody
,” J. Phys. Chem. B
125
, 7368
–7379
(2021
).38.
H.
Nguyen
, P. D.
Lan
, D. A.
Nissley
, E. P.
O’Brien
, and M. S.
Li
, “Cocktail of REGN antibodies binds more strongly to SARS-CoV-2 than its components, but the omicron variant reduces its neutralizing ability
,” J. Phys. Chem. B
126
, 2812
–2823
(2022
).39.
R.
Zhu
, D.
Canena
, M.
Sikora
, M.
Klausberger
, H.
Seferovic
, A. R.
Mehdipour
, L.
Hain
, E.
Laurent
, V.
Monteil
, G.
Wirnsberger
, R.
Wieneke
, R.
Tampé
, N. F.
Kienzl
, L.
Mach
, A.
Mirazimi
, Y. J.
Oh
, J. M.
Penninger
, G.
Hummer
, and P.
Hinterdorfer
, “Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule level
,” Nat. Commun.
13
, 7926
(2022
).40.
J.
Yang
, S. J. L.
Petitjean
, M.
Koehler
, Q.
Zhang
, A. C.
Dumitru
, W.
Chen
, S.
Derclaye
, S. P.
Vincent
, P.
Soumillion
, and D.
Alsteens
, “Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor
,” Nat. Commun.
11
, 4541
(2020
).41.
M.
Koehler
, A.
Ray
, R. A.
Moreira
, B.
Juniku
, A. B.
Poma
, and D.
Alsteens
, “Molecular insights into receptor binding energetics and neutralization of SARS-CoV-2 variants
,” Nat. Commun.
12
, 6977
(2021
).42.
K. P.
Hui
, J. C.
Ho
, M.-c.
Cheung
, K.-c.
Ng
, R. H.
Ching
, K.-l.
Lai
, T. T.
Kam
, H.
Gu
, K.-Y.
Sit
,
M. K.
Hsin
et al, “SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo
,” Nature
603
, 715
–720
(2022
).43.
M. M.
Lamers
, A. Z.
Mykytyn
, T. I.
Breugem
, N.
Groen
, K.
Knoops
, D.
Schipper
, R.
van Acker
, P. B.
van den Doel
, T.
Bestebroer
, and C. D.
Koopman
, “SARS-CoV-2 Omicron efficiently infects human airway, but not alveolar epithelium
,” bioRxiv: (2022
).44.
W.
Cao
, C.
Dong
, S.
Kim
, D.
Hou
, W.
Tai
, L.
Du
, W.
Im
, and X. F.
Zhang
, “Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein
interaction
,” Biophys. J.
120
, 1011
–1019
(2021
).45.
X.
Zhang
, B.
Hong
, P.
Wei
, P.
Pei
, H.
Xu
, L.
Chen
, Y.
Tong
, J.
Chen
, S.-Z.
Luo
, H.
Fan
, and C.
He
, “Pathogen-host adhesion between SARS-CoV-2 spike proteins from different variants and human ACE2 studied at single-molecule and single-cell levels
,” Emerging Microbes Infect.
11
, 2658
–2669
(2022
).46.
W.
Zhang
, K.
Shi
, Q.
Geng
, M.
Herbst
, M.
Wang
, L.
Huang
, F.
Bu
, B.
Liu
, H.
Aihara
, and F.
Li
, “Structural evolution of SARS-CoV-2 omicron in human receptor recognition
,” J. Virol.
97
, e00822
–e00823
(2023
).47.
D. A.
Nissley
, Q. V.
Vu
, F.
Trovato
, N.
Ahmed
, Y.
Jiang
, M. S.
Li
, and E. P.
O’Brien
, “Electrostatic interactions govern extreme nascent protein ejection times from ribosomes and can delay ribosome recycling
,” J. Am. Chem. Soc.
142
, 6103
–6110
(2020
).48.
J.
Karanicolas
and C. L.
Brooks
III, “The origins of asymmetry in the folding transition states of protein L and protein G
,” Protein Sci.
11
, 2351
–2361
(2002
).49.
R. B.
Best
, Y.-G.
Chen
, and G.
Hummer
, “Slow protein conformational dynamics from multiple experimental structures: The helix/sheet transition of arc repressor
,” Structure
13
, 1755
–1763
(2005
).50.
E. P.
O’Brien
, J.
Christodoulou
, M.
Vendruscolo
, and C. M.
Dobson
, “Trigger factor slows co-translational folding through kinetic trapping while sterically protecting the nascent chain from aberrant cytosolic interactions
,” J. Am. Chem. Soc.
134
, 10920
–10932
(2012
).51.
M. R.
Betancourt
and D.
Thirumalai
, “Pair potentials for protein folding: Choice of reference states and sensitivity of predicted native states to variations in the interaction schemes
,” Protein Sci.
8
, 361
–369
(1999
).52.
S. E.
Leininger
, F.
Trovato
, D. A.
Nissley
, and E. P.
O’Brien
, “Domain topology, stability, and translation speed determine mechanical force generation on the ribosome
,” Proc. Natl. Acad. Sci. U. S. A.
116
, 5523
–5532
(2019
).53.
J.
Karanicolas
and C. L.
Brooks
III, “Improved Gō-like models demonstrate the robustness of protein folding mechanisms towards non-native interactions
,” J. Mol. Biol.
334
, 309
–325
(2003
).54.
Y.
Sugita
, A.
Kitao
, and Y.
Okamoto
, “Multidimensional replica-exchange method for free-energy calculations
,” J. Chem. Phys.
113
, 6042
–6051
(2000
).55.
B. R.
Brooks
, C. L.
Brooks
III, A. D.
Mackerell
, Jr., L.
Nilsson
, R. J.
Petrella
, B.
Roux
, Y.
Won
, G.
Archontis
, C.
Bartels
, S.
Boresch
, A.
Caflisch
, L.
Caves
, Q.
Cui
, A. R.
Dinner
, M.
Feig
, S.
Fischer
, J.
Gao
, M.
Hodoscek
, W.
Im
, K.
Kuczera
, T.
Lazaridis
, J.
Ma
, V.
Ovchinnikov
, E.
Paci
, R. W.
Pastor
, C. B.
Post
, J. Z.
Pu
,
M.
Schaefer
, B.
Tidor
, R. M.
Venable
, H. L.
Woodcock
, X.
Wu
, W.
Yang
, D. M.
York
, and M.
Karplus
, “CHARMM: The biomolecular simulation program
,” J. Comput. Chem.
30
,
1545
–1614
(2009
).56.
S.
Kumar
, J. M.
Rosenberg
, D.
Bouzida
, R. H.
Swendsen
, and P. A.
Kollman
, “The weighted histogram analysis method for free-energy calculations on biomolecules. I. The method
,” J. Comput. Chem.
13
, 1011
–1021
(1992
).57.
M. S.
Bauer
, S.
Gruber
, A.
Hausch
, P. S.
Gomes
, L. F.
Milles
, T.
Nicolaus
, L. C.
Schendel
, P. L.
Navajas
, E.
Procko
, D.
Lietha
et al, “A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions
,” Proc. Natl. Acad. Sci. U. S. A.
119
, e2114397119
(2022
).58.
C. S.
Lupala
, Y.
Ye
, H.
Chen
, X. D.
Su
, and H.
Liu
, “Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor
,” Biochem. Biophys. Res. Commun.
590
, 34
–41
(2022
).59.
T. A.
Shishir
, T.
Jannat
, and I. B.
Naser
, “An in-silico study of the mutation-associated effects on the spike protein of SARS-CoV-2, Omicron variant
,” PLoS One
17
, e0266844
(2022
).60.
G. I.
Bell
, “Models for the specific adhesion of cells to cells: A theoretical framework for adhesion mediated by reversible bonds between cell surface molecules
,” Science
200
, 618
–627
(1978
).61.
E.
Evans
and K.
Ritchie
, “Dynamic strength of molecular adhesion bonds
,” Biophys. J.
72
, 1541
–1555
(1997
).62.
N. L.
Miller
, T.
Clark
, R.
Raman
, and R.
Sasisekharan
, “Insights on the mutational landscape of the SARS-CoV-2 Omicron variant receptor-binding domain
,” Cell Rep. Med.
3
, 100527
(2022
).63.
W.
Dejnirattisai
, J.
Huo
, D.
Zhou
, J.
Zahradník
, P.
Supasa
, C.
Liu
, H. M.
Duyvesteyn
, H. M.
Ginn
, A. J.
Mentzer
, A.
Tuekprakhon
et al, “SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
,” Cell
185
, 467
–484.e15
(2022
).64.
M.
Alkhatib
, R.
Salpini
, L.
Carioti
, F. A.
Ambrosio
, S.
D’Anna
, L.
Duca
, G.
Costa
, M. C.
Bellocchi
, L.
Piermatteo
, A.
Artese
et al, “Update on SARS-CoV-2 omicron variant of concern and its peculiar mutational profile
,” Microbiol. Spectrum
10
, e02732
–e02721
(2022
).65.
Z.-S.
Yan
, Y.
Xu
, H.-M.
Ding
, and Y.-Q.
Ma
, “Molecular insights into striking antibody evasion of SARS-CoV-2 Omicron variant
,” Chin. Phys. Lett.
39
, 108701
(2022
).66.
T.-J.
Yang
, P.-Y.
Yu
, Y.-C.
Chang
, K.-H.
Liang
, H.-C.
Tso
, M.-R.
Ho
, W.-Y.
Chen
, H.-T.
Lin
, H.-C.
Wu
,
and S.-T. D.
Hsu
, “Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function
,” Nat. Struct. Mol. Biol.
28
, 731
–739
(2021
).67.
Y.
Liu
, J.
Liu
, K. S.
Plante
, J. A.
Plante
, X.
Xie
, X.
Zhang
, Z.
Ku
, Z.
An
, D.
Scharton
, C.
Schindewolf
, S. G.
Widen
, V. D.
Menachery
, P. Y.
Shi
, and S. C.
Weaver
, “The N501Y spike substitution enhances SARS-CoV-2 infection and transmission
,” Nature
602
, 294
–299
(2022
).68.
T. N.
Starr
, A. J.
Greaney
, S. K.
Hilton
, D.
Ellis
, K. H.
Crawford
, A. S.
Dingens
, M. J.
Navarro
, J. E.
Bowen
, M. A.
Tortorici
, A. C.
Walls
et al, “Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding
,” Cell
182
, 1295
–1310.e20
(2020
).69.
J.
Zahradník
, A.
Tuekprakhon
, H.
Ginn
, H. M. E.
Duyvesteyn
, M.
Bahar
, S.
Khan
, O.
Avinoam
, D.
Zhou
, R.
Nutalai
, P.
Supasa
, B.
Wang
, W.
Dejnirattisai
, C.
Liu
, A.
Dijokaite
, N.
Temperton
, J.
Mongkolspaya
, E.
Fry
, R.
Jingshan
, G.
Screaton
, G.
Schreiber
, and D.
Stuart
, SSRN, 2021
.70.
J.
Zahradník
, S.
Marciano
, M.
Shemesh
, E.
Zoler
, D.
Harari
, J.
Chiaravalli
, B.
Meyer
, Y.
Rudich
, C.
Li
,
I.
Marton
et al, “SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution
,” Nat. Microbiol.
6
, 1188
–1198
(2021
).71.
T. N.
Starr
, A. J.
Greaney
, C. M.
Stewart
, A. C.
Walls
, W. W.
Hannon
, D.
Veesler
, and J. D.
Bloom
, “Deep mutational scans for ACE2 binding, RBD expression, and antibody escape in the SARS-CoV-2 Omicron BA.1 and BA.2 receptor-binding domains
,” PLoS
Pathog.
18
, e1010951
(2022
).72.
G.
Verkhivker
, M.
Alshahrani
, and G.
Gupta
, “Balancing functional tradeoffs between protein stability and ACE2 binding in the SARS-CoV-2 omicron BA.2, BA.2.75 and XBB lineages: Dynamics-based network models reveal epistatic effects modulating compensatory dynamic and energetic changes
,” Viruses
15
, 1143
(2023
).73.
V. S. D.
Mesias
, H.
Zhu
, X.
Tang
, X.
Dai
, W.
Liu
, Y.
Guo
, and J.
Huang
, “Moderate binding between two SARS-CoV-2 protein segments and α-synuclein alters its toxic oligomerization propensity differently
,” J. Phys. Chem. Lett.
13
, 10642
–10648
(2022
).74.
A. K.
Jana
, C. W.
Lander
, A. D.
Chesney
, and U. H. E.
Hansmann
, “Effect of an amyloidogenic SARS-COV-2 protein fragment on α-synuclein monomers and fibrils
,” J. Phys. Chem. B
126
, 3648
–3658
(2022
).75.
A. D.
Chesney
, B.
Maiti
, and U. H. E.
Hansmann
, “SARS-COV-2 spike protein fragment eases amyloidogenesis of α-synuclein
,” J. Chem. Phys.
159
, 015103
(2023
).76.
E.
Cameroni
, J. E.
Bowen
, L. E.
Rosen
, C.
Saliba
, S. K.
Zepeda
, K.
Culap
, D.
Pinto
, L. A.
VanBlargan
, A.
De
Marco
, J.
di Iulio
, F.
Zatta
, H.
Kaiser
, J.
Noack
, N.
Farhat
, N.
Czudnochowski
, C.
Havenar-Daughton
, K. R.
Sprouse
, J. R.
Dillen
, A. E.
Powell
, A.
Chen
, C.
Maher
, L.
Yin
, D.
Sun
, L.
Soriaga
, J.
Bassi
, C.
Silacci-Fregni
, C.
Gustafsson
, N. M.
Franko
, J.
Logue
, N. T.
Iqbal
, I.
Mazzitelli
, J.
Geffner
, R.
Grifantini
, H.
Chu
, A.
Gori
, A.
Riva
, O.
Giannini
, A.
Ceschi
, P.
Ferrari
, P. E.
Cippa
, A.
Franzetti-Pellanda
, C.
Garzoni
, P. J.
Halfmann
, Y.
Kawaoka
, C.
Hebner
, L. A.
Purcell
, L.
Piccoli
, M. S.
Pizzuto
, A. C.
Walls
, M. S.
Diamond
, A.
Telenti
, H. W.
Virgin
, A.
Lanzavecchia
, G.
Snell
, D.
Veesler
, and D.
Corti
, “Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
,” Nature
602
, 664
–670
(2021
).77.
W.
Yin
, Y.
Xu
, P.
Xu
, X.
Cao
, C.
Wu
, C.
Gu
, X.
He
, X.
Wang
, S.
Huang
, Q.
Yuan
, K.
Wu
, W.
Hu
, Z.
Huang
, J.
Liu
, Z.
Wang
, F.
Jia
, K.
Xia
, P.
Liu
, X.
Wang
,
B.
Song
, J.
Zheng
, H.
Jiang
, X.
Cheng
, Y.
Jiang
, S. J.
Deng
, and H. E.
Xu
, “Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody
,” Science
375
, 1048
–1053
(2022
).78.
J.
Zhang
, Y.
Cai
, C. L.
Lavine
, H.
Peng
, H.
Zhu
, K.
Anand
, P.
Tong
, A.
Gautam
, M. L.
Mayer
,
S.
Rits-Volloch
, S.
Wang
, P.
Sliz
, D. R.
Wesemann
, W.
Yang
, M. S.
Seaman
, J.
Lu
, T.
Xiao
, and B.
Chen
, “Structural and functional
impact by SARS-CoV-2 Omicron spike mutations
,” Cell Rep.
39
, 110729
(2022
).79.
Q.
Wang
, Y.
Guo
, S.
Iketani
, M. S.
Nair
, Z.
Li
, H.
Mohri
, M.
Wang
, J.
Yu
, A. D.
Bowen
, J. Y.
Chang
et al, “Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5
,” Nature
608
, 603
–608
(2022
).80.
Q.
Hong
, W.
Han
, J.
Li
, S.
Xu
, Y.
Wang
, C.
Xu
, Z.
Li
, Y.
Wang
, C.
Zhang
, Z.
Huang
, and Y.
Cong
, “Molecular basis of receptor binding and antibody neutralization of Omicron
,” Nature
604
, 546
–552
(2022
).81.
J.
Lan
, X.
He
, Y.
Ren
, Z.
Wang
, H.
Zhou
, S.
Fan
, C.
Zhu
, D.
Liu
, B.
Shao
, and T.-Y.
Liu
, “Structural and computational insights into the SARS-CoV-2 Omicron RBD-ACE2 interaction
,” Cell Res.
32
, 593
(2022
).82.
Y.
Cao
, A.
Yisimayi
, F.
Jian
, W.
Song
, T.
Xiao
, L.
Wang
, S.
Du
, J.
Wang
, Q.
Li
, X.
Chen
et al, “BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
,” Nature
608
, 593
–602
(2022
).83.
L.
Li
, H.
Liao
, Y.
Meng
, W.
Li
, P.
Han
, K.
Liu
, Q.
Wang
, D.
Li
, Y.
Zhang
, L.
Wang
et al, “Structural basis of human ACE2 higher binding affinity to currently circulating Omicron SARS-CoV-2 sub-variants BA.2 and BA.1.1
,” Cell
185
, 2952
–2960e10
(2022
).84.
J. E.
Bowen
, A.
Addetia
, H. V.
Dang
, C.
Stewart
, J. T.
Brown
, W. K.
Sharkey
, K. R.
Sprouse
, A. C.
Walls
, I. G.
Mazzitelli
, J. K.
Logue
, N. M.
Franko
, N.
Czudnochowski
, A. E.
Powell
, E.
Dellota
, Jr., K.
Ahmed
, A. S.
Ansari
, E.
Cameroni
, A.
Gori
, A.
Bandera
, C. M.
Posavad
, J. M.
Dan
, Z.
Zhang
, D.
Weiskopf
, A.
Sette
, S.
Crotty
, N. T.
Iqbal
, D.
Corti
,
J.
Geffner
, G.
Snell
, R.
Grifantini
, H. Y.
Chu
, and D.
Veesler
, “Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines
,” Science
377
, 890
–894
(2022
).85.
X.
Zhang
, S.
Wu
, B.
Wu
, Q.
Yang
, A.
Chen
, Y.
Li
, Y.
Zhang
, T.
Pan
, H.
Zhang
, and X.
He
, “SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance
,” Signal Transduction Targeted Ther.
6
, 430
(2021
).86.
A.
Addetia
, L.
Piccoli
, J. B.
Case
, Y.-J.
Park
, M.
Beltramello
, B.
Guarino
, H.
Dang
, G. D.
de Melo
, D.
Pinto
, K.
Sprouse
et al, “Neutralization, effector function and immune imprinting of Omicron variants
,” Nature
621
, 592
–601
(2023
).87.
P.
Han
, L.
Li
, S.
Liu
, Q.
Wang
, D.
Zhang
, Z.
Xu
, P.
Han
, X.
Li
, Q.
Peng
, C.
Su
et al, “Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
,” Cell
185
, 630
–640.e10
(2022
).88.
M.
Schubert
, F.
Bertoglio
, S.
Steinke
, P. A.
Heine
, M. A.
Ynga-Durand
, H.
Maass
, J. C.
Sammartino
, I.
Cassaniti
, F.
Zuo
, L.
Du
et al, “Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant
,” BMC Med.
20
, 102
(2022
).© 2024 Author(s). Published under an exclusive license by AIP Publishing.
2024
Author(s)
You do not currently have access to this content.
